Ex Vivo Test of New Stroke Treatment Using Magnetic Nanorobots

Inclusion Criteria: * Healthy pregnant women at 20-45 years of age of any ethic origin, giving childbirth with natural delivery or caesarean sections after 37-42 weeks of gestation. * Healthy singleton pregnancy. * Participant able to give voluntary, written, informed consent to participate in the study. Exclusion Criteria: * Abnormal prenatal development (e.g intrauterine growth restriction) * Early preterm birth \< 37 weeks * Verbal Confirmation of hypercholesterolemia * Family history of stroke or vascular disease * Type I or Type II diabetes and gestational diabetes * Cancer, except skin cancers completely excised with no chemotherapy or radiation with a follow up that is negative. * Clinically significant abnormal laboratory results at screening. * Any other active or unstable medical condition. * History of liver disease. * History of hypertension (including pre-eclampsia)